October 30, 2009 – Intercell AG today announced that the Health Canada granted product approval for IXIARO®, the company?s vaccine to prevent Japanese Encephalitis (JE). This decision of the Canadian authorities represents another important milestone for the product?s global reach. Intercell?s vaccine to prevent Japanese Encephalitis has already been successfully approved and launched in the USA, Europe and Australia.
The details can be read here.
No comments:
Post a Comment